Key result
High glucose triggers osteogenic signaling and drives calcification in 3D human valve models.
Why the study?
Calcific aortic valve disease is accelerated in diabetes without pharmacotherapy, but the molecular mechanisms involved in diabetes-associated CAVD remain to be uncovered.
Does high glucose exposure increase osteogenic molecule expression and calcification in a 3D model of human valvular cells?
Does high glucose exposure increase osteogenic molecule expression and calcification in a 3D model of human valvular cells?
p-value: p=<0.05
High glucose exposure in a 3D human valvular cell model upregulates osteogenic pathways and increases calcium deposits, providing insight into diabetes-associated calcific aortic valve disease.
May link hyperglycemia to valve calcification mechanistically; hypothesis-generating for targeted interventions in diabetes.
Calcific aortic valve disease (CAVD)-the most common valvular heart disease-is accelerated in diabetes and has no pharmacotherapy. Although it is known that early CAVD is associated with inflammation and osteogenesis, the molecular mechanisms involved in diabetes-associated CAVD still need to be uncovered. In this context, we have developed a 3D construct based on gelatin populated with human valvular endothelial cells (VEC) and valvular interstitial cells (VIC) and evaluated the effect of high glucose (HG) concentration on osteogenic molecules expression and on calcification mechanisms. First, we characterized the 3D model and assessed VIC remodelling properties at different time-points. Then, we exposed it to normal glucose (NG) or high glucose (HG) for 7, 14 and 21 days after which the cells were isolated, separated and investigated individually. Our results showed that encapsulated VIC actively remodel the hydrogel, as demonstrated by an increased expression of extracellular matrix (ECM) proteins and matrix metalloproteinases (MMPs). Moreover, exposure of the construct to HG triggered bone morphogenetic protein (BMP) and TGF-β signalling pathways, up-regulating expression of osteogenic molecules-BMP-2/-4, osteocalcin, osteopontin, SMADs and Runt-related transcription factor (Runx-2)-and increased calcium deposits in an osteogenic environment. These findings underline the potential of the developed 3D model as a suitable system to investigate the mechanisms of human CAVD and may help to better understand the calcification mechanisms in CAVD associated to diabetes.
No takes yet. Share an insight, caveat, or question.
Vadana et al. (2020) studied Calcific aortic valve disease (n=3). High glucose vs. Normal glucose (5 mmol/L) was evaluated on Expression of osteogenic molecules and calcium deposits in a 3D valve construct (p=<0.05). Exposure of 3D human valvular constructs to high glucose triggered BMP and TGF-β signaling pathways, up-regulated osteogenic molecules, and significantly increased calcium deposits.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: